Publication dates

All regions

Therapeutics Industry, September 2014 Market Reports from Top Publishers

You might be interested in: drug, medical equipment, cancer, more »


 
1-20 of about 2 900 reports for Therapeutics

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

  • $ 2 995
  • Industry report
  • September 2014
  • by Currentpartnering

The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the clinical stage partnering deals and agreements entered ...

Boston Therapeutics Inc

Boston Therapeutics Inc

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

... Boston therapeutics inc a textual analysis of the financial results for boston therapeutics inc compared to selected competitors. Also included are quantitative analyses of the company's financial ...

Nektar Therapeutics

Nektar Therapeutics

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

... therapeutics are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub-industry, fiscal year end month, employees, share ...

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

... Included for halozyme therapeutics, inc. Are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub-industry, fiscal ...

Errant Gene Therapeutics, LLC - Product Pipeline Review - 2014

Errant Gene Therapeutics, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

... The report summarizes all the dormant and discontinued pipeline projects- latest company statement - latest news and deals relating to the errant gene therapeutics, llc's pipeline products ...

Pique Therapeutics - Product Pipeline Review - 2014

Pique Therapeutics - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

... Latest company statement - latest news and deals relating to the pique therapeutics's pipeline productsreasons to buy- evaluate pique therapeutics's strategic position with total ...

Alethia Biotherapeutics Inc. - Product Pipeline Review - 2014

Alethia Biotherapeutics Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

... Areas of focus- identify new drug targets and therapeutic classes in the alethia biotherapeutics inc.'S r&d portfolio and develop key strategic initiatives to reinforce pipeline in those areas ...

Relmada Therapeutics, Inc. - Product Pipeline Review - 2014

Relmada Therapeutics, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

... Attractive projects to enhance and expand business potential and scope- explore the dormant and discontinued projects of relmada therapeutics, inc. And identify potential opportunities in those areas ...

Celsus Therapeutics Plc - Product Pipeline Review - 2014

Celsus Therapeutics Plc - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

... Latest company statement - latest news and deals relating to the celsus therapeutics plc's pipeline productsreasons to buy- evaluate celsus therapeutics plc's strategic position ...

Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) - Global Forecast to 2023

Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) - Global Forecast to 2023

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

... The growth of the human microbiome market. The application market is also expected to be a prominent segment owing to the use of microbiome as diagnostics and therapeutics. The evidence from intransigent ...

About 13 000 reports for Therapeutics

Download Unlimited Documents from Trusted Public Sources

Drug PPI in Canada - Forecast

  • Potential Costs from Therapeutic Substitution of Proton Pump Inh...
  • August 2013
    10 pages
  • Drug  

  • Canada  

    United Kingdom  

    North America  

View report >

Drug Spending In Canada

December 2013

57 Companies for Therapeutics

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.